These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 10363024)

  • 81. Imbalanced base excision repair increases spontaneous mutation and alkylation sensitivity in Escherichia coli.
    Posnick LM; Samson LD
    J Bacteriol; 1999 Nov; 181(21):6763-71. PubMed ID: 10542179
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Synthesis, DNA binding and cytotoxicity of 1-[[omega-(9-acridinyl)amino]alkyl]carbonyl -3-(chloromethyl)-6-hydroxyindolines, a new class of DNA-targeted alkylating agents.
    Fan JY; Tercel M; Denny WA
    Anticancer Drug Des; 1997 Jun; 12(4):277-93. PubMed ID: 9199660
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Release of 3-methyladenine from linker and core DNA of chromatin by a purified DNA glycosylase.
    Heller EP; Goldthwait DA
    Cancer Res; 1983 Dec; 43(12 Pt 1):5747-53. PubMed ID: 6640526
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Intact MutY and its catalytic domain differentially contact with A/8-oxoG-containing DNA.
    Li X; Lu AL
    Nucleic Acids Res; 2000 Dec; 28(23):4593-603. PubMed ID: 11095667
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cloning of Escherichia coli genes encoding 3-methyladenine DNA glycosylases I and II.
    Clarke ND; Kvaal M; Seeberg E
    Mol Gen Genet; 1984; 197(3):368-72. PubMed ID: 6098799
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Mismatch repair of cis-diamminedichloroplatinum(II)-induced DNA damage.
    Fram RJ; Cusick PS; Wilson JM; Marinus MG
    Mol Pharmacol; 1985 Jul; 28(1):51-5. PubMed ID: 3894930
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The alkylating antitumor drug tallimustine does not induce DNA repair.
    Rossi R; Montecucco A; Capolongo L; Mezzina M; Chevallier-Lagente O; Sarasin A; Ciarrocchi G
    Anticancer Res; 1996; 16(6B):3779-83. PubMed ID: 9042257
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Tallimustine lesions in cellular DNA are AT sequence-specific but not region-specific.
    Herzig MC; Trevino AV; Arnett B; Woynarowski JM
    Biochemistry; 1999 Oct; 38(42):14045-55. PubMed ID: 10529251
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Interplay between base excision repair activity and toxicity of 3-methyladenine DNA glycosylases in an E. coli complementation system.
    Troll CJ; Adhikary S; Cueff M; Mitra I; Eichman BF; Camps M
    Mutat Res; 2014; 763-764():64-73. PubMed ID: 24709477
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effect of distamycin on chlorambucil-induced mutagenesis in pZ189: evidence of a role for minor groove alkylation at adenine N-3.
    Wang P; Bauer GB; Kellogg GE; Abraham DJ; Povirk LF
    Mutagenesis; 1994 Mar; 9(2):133-9. PubMed ID: 8201946
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Structure-activity relationship of a series of C-terminus modified aminoalkyl, diaminoalkyl- and anilino-containing analogues of the benzoic acid mustard distamycin derivative tallimustine: synthesis, DNA binding and cytotoxicity studies.
    Brooks N; Hartley JA; Simpson JE; Wright SR; Woo S; Centioni S; Fontaine MD; McIntyre TE; Lee M
    Bioorg Med Chem; 1997 Aug; 5(8):1497-507. PubMed ID: 9313856
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Escherichia coli, Saccharomyces cerevisiae, rat and human 3-methyladenine DNA glycosylases repair 1,N6-ethenoadenine when present in DNA.
    Saparbaev M; Kleibl K; Laval J
    Nucleic Acids Res; 1995 Sep; 23(18):3750-5. PubMed ID: 7479006
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Processing of N
    Minko IG; Christov PP; Li L; Stone MP; McCullough AK; Lloyd RS
    DNA Repair (Amst); 2019 Jan; 73():49-54. PubMed ID: 30448017
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A New Cross-Link for an Old Cross-Linking Drug: The Nitrogen Mustard Anticancer Agent Mechlorethamine Generates Cross-Links Derived from Abasic Sites in Addition to the Expected Drug-Bridged Cross-Links.
    Nejad MI; Johnson KM; Price NE; Gates KS
    Biochemistry; 2016 Dec; 55(50):7033-7041. PubMed ID: 27992994
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Monofunctional adenine N-3 adducts of melphalan: occurrence at a mutational hotspot sequence and resistance to removal by AlkA protein.
    Charles K; Bauer GB; Povirk LF
    Environ Mol Mutagen; 1998; 31(4):333-9. PubMed ID: 9654242
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comparison of the biological effects of MMS and Me-lex, a minor groove methylating agent: clarifying the role of N3-methyladenine.
    Monti P; Foggetti G; Menichini P; Inga A; Gold B; Fronza G
    Mutat Res; 2014 Jan; 759():45-51. PubMed ID: 24211855
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Inhibition of enzymic incision of thymine dimers by covalently bound guanine adducts of 4-nitroquinoline-1-oxide in DNA.
    Duker NJ; Merkel GW
    Cancer Res; 1986 May; 46(5):2374-6. PubMed ID: 3084066
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Saccharomyces cerevisiae 3-methyladenine DNA glycosylase has homology to the AlkA glycosylase of E. coli and is induced in response to DNA alkylation damage.
    Chen J; Derfler B; Samson L
    EMBO J; 1990 Dec; 9(13):4569-75. PubMed ID: 2265620
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Recent outcome in the field of distamycin-derived minor groove binders.
    Cozzi P
    Farmaco; 2000 Mar; 55(3):168-73. PubMed ID: 10919073
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The inefficiency of incisions of ecteinascidin 743-DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent.
    Zewail-Foote M; Li VS; Kohn H; Bearss D; Guzman M; Hurley LH
    Chem Biol; 2001 Nov; 8(11):1033-49. PubMed ID: 11731295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.